In the field of MR radiogenomics research, many imaging-based characteristics (tumour localization, mass effect, tumour contrast enhancement, etc.)are correlated with molecular genetic biomarkers (EGFR, IDH/1p19q subtype, TP53 mutation status, etc.)that are used to identify their phenotypes upon imaging [8, 11–15]. The gene discussed is EGFR; the disease is neoplasm.